NCT06635265

Brief Summary

This Proof-of-Concept study will collect acute and sub-acute flow and/or AHI data following the placement of lead arrays under direct vision. The acute placement and data collection will be collected following the completion of the pre-scheduled neck dissection surgery. The sub-acute data will be collected in a sleep lab during a polysomnography (PSG). Both data collections will be done when stimulating (using an external pulse generator) the hypoglossal nerve or Genioglossus muscle (GG) and a second neural target (Ansa Cervicalis - AC) or the strap muscles (sternohyoid and sternothyroid) with a set of Off-the-Shelf (OTS) electrode arrays.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 3, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2024

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 10, 2024

Completed
Last Updated

October 10, 2024

Status Verified

October 1, 2024

Enrollment Period

1.2 years

First QC Date

October 2, 2024

Last Update Submit

October 8, 2024

Conditions

Keywords

Sleep Apnea device

Outcome Measures

Primary Outcomes (2)

  • Impacts on acute airway opening

    Demonstration of acute airway opening as visually observed under nasoendoscopy when stimulating the HGN or GG and a second target (neural or direct muscle stimulation).

    Day 0 to 3

  • Impacts on airflow during a acute assessment

    Acute increase in airflow when stimulating the HGN or GG and a second target (neural or direct muscle stimulation), measured by changes in amplitude (mA) during target stimulation.

    Day 0 to 3

Secondary Outcomes (1)

  • Impacts on airway opening during a sub-acute assessment

    Day 0 to 3

Study Arms (1)

Target stimulation

EXPERIMENTAL

Stimulation of a combination of targets: Hypoglossal nerve (HGN) and Ansa Cervicalis (AC), Genioglossus (GG) and AC, HGN and strap muscles, or GG and strap muscles, during an acute and sub-acute phase.

Device: Target Stimulation (HGN, AC, GG, Strap muscles)

Interventions

Simulation of a combination of: HGN, AC, GG or strap muscles

Target stimulation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age above 18 years not under guardianship, under curatorship or under judicial protection.
  • Body Mass Index (BMI) \< 38 kg/m2.
  • Subject must be eligible for neck dissection surgery.
  • Written informed consent obtained from the patient prior to performing any study specific procedure.
  • Willing and capable to comply with all study requirements, including specific lifestyle considerations, evaluation procedures and questionnaires for the whole duration of the trial.

You may not qualify if:

  • Patients meeting any of the following criteria will be excluded from participation in this study:
  • Major anatomical or functional abnormalities that would impair the ability of the electrode arrays to be positioned.
  • Significant comorbidities that contraindicate surgery or general anesthesia.
  • Significant tongue weakness.
  • Aerodigestive tract tumor or reconstructive surgery performed at the same time as neck dissection.
  • Any other chronic medical illness or condition that contraindicates a surgical procedure or general anesthesia in the judgment of the investigator.
  • Prior surgery or treatments that could compromise the placement and effectiveness of the electrode array systems:
  • Airway cancer surgery or radiation, or
  • Mandible or maxilla surgery in the previous 3 years (not counting dental treatments).
  • Other upper airway surgery to remove obstructions related to OSA in the previous 3 months (e.g., uvulopalatopharyngoplasty (UPPP), tonsillectomy, nasal airway surgery).
  • Prior hypoglossal nerve stimulation device implantation.
  • Currently pregnant or breastfeeding during the study period.
  • Concomitant oral or pharyngeal surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Perth Head and Neck Surgery

Perth, Western Australia, 6009, Australia

Location

MeSH Terms

Conditions

Sleep Apnea SyndromesSleep Apnea, ObstructiveSleep Wake Disorders

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Electrode arrays placed adjacent to nerves are connected to an external pulse generator to evaluate the effect of short-term stimulation on airflow and/or AHI
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2024

First Posted

October 10, 2024

Study Start

April 3, 2023

Primary Completion

June 28, 2024

Study Completion

July 1, 2024

Last Updated

October 10, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations